MAXILUS
A Phase 3b, Open-label Study Evaluating the Efficacy and Safety of Luspatercept (BMS-986346/ACE-536) Initiated at Maximum Approved Dose in LR-MDS With IPSS-R Very Low-, Low-, or Intermediate-risk Who Require RBC Transfusions (MAXILUS)
Filters
Save & Share
Clear Filters
Location
Explore options near your center - or near your patient's home.
MDS Centers of Excellence
Diagnosis
Purpose of Trial
Filter and find trials based on their purpose.
Risk Level
Enter this patient's risk level (IPSS-R / IPSS-M).
Near Add Your Location
Sort by
Cancer and Blood Specialty Clinic
Los Alamitos, CA
- Accepting patients
Center of Excellence
Smilow Cancer Hospital at Yale New Haven
New Haven, CT
- Accepting patients
Center of Excellence
University of Kansas Cancer Center
Kansas City, KS
- Accepting patients
- Accepting patients
Henry Ford Hospital
Detroit, MI
- Accepting patients
Center of Excellence
- Accepting patients
Oncology Associates of Oregon
Eugene, OR
- Accepting patients
Center of Excellence
West Penn Hospital (Allegheny Health Network)
Pittsburgh, PA
- Accepting patients
- Accepting patients
Wheeling Hospital Schiffler Cancer Center
Wheeling, WV
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.